Literatur
Pellegrino R, Viegi G, Brusasco V et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-68
Stanojevic S, Kaminsky DA, Miller MR et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60:2101499
Global Inititiave for Chronic Obstructive Lunge Disease: 2024 Report. www.goldcopd.org (Zugriff am 2.3.2024)
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2023. Update vom Juli 2023. www.ginasthma.org (Zugriff am 2.3.2024)
Lommatzsch M, Criée CP, de Jong CCM et al. S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023. Pneumologie. 2023;77:461-543
Janson C, Malinovschi A, Amaral AFS et al. Bronchodilator reversibility in asthma and COPD: findings from three large population studies. Eur Respir J. 2019;54:1900561
Tuomisto LE, Ilmarinen P, Lehtima L et al. Immediate bronchodilator response in FEV1 as a diagnostic criterion for adult asthma. Eur Respir J. 2019;53:1800904
Appleton SL, Adams RJ, Wilson DH et al. North West Adelaide Cohort Health Study Team. Spirometric criteria for asthma: adding further evidence to the debate. J Allergy Clin Immunol. 2005;116:976-82
Agusti A, Bel E, Thomas M et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47:410-9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gillissen, A. Bronchodilatationstest bei Asthma und COPD: Nutzen und Grenzen. Pneumo News 16, 24–25 (2024). https://doi.org/10.1007/s15033-024-3989-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-024-3989-7